Login | Register

Two GSK Skin Cancer Drugs Approved By FDA

Two new GlaxoSmithKline (GSK) drugs, Tafinlar (dabrafenib) and Mekinist (trametinib), have been approved for the treatment of patients with advanced melanoma by the U.S. Food and Drug Administration (FDA). Melanoma is the most dangerous form of skin cancer and the number one cause of death from skin disease...

Read More

Leave a Reply

Your email address will not be published. Required fields are marked *